Zuckerman Investment Group’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-41,483
Closed -$36K 82
2019
Q4
$36K Sell
41,483
-265
-0.6% -$203 0.01% 67
2019
Q3
$23K Hold
41,748
0.01% 66
2019
Q2
$22K Sell
41,748
-195
-0.5% -$97 ﹤0.01% 65
2019
Q1
$19K Sell
41,943
-585
-1% -$273 ﹤0.01% 63
2018
Q4
$20K Hold
42,528
0.01% 59
2018
Q3
$23K Hold
42,528
0.01% 61
2018
Q2
$21K Sell
42,528
-150
-0.4% -$70 ﹤0.01% 58
2018
Q1
$18K Hold
42,678
﹤0.01% 56
2017
Q4
$16K Sell
42,678
-320
-0.7% -$121 ﹤0.01% 54
2017
Q3
$15K Sell
42,998
-150
-0.3% -$56 ﹤0.01% 51
2017
Q2
$16K Sell
43,148
-774
-2% -$316 ﹤0.01% 52
2017
Q1
$20K Sell
43,922
-50
-0.1% -$22 ﹤0.01% 58
2016
Q4
$17K Sell
43,972
-20
-0% -$7 ﹤0.01% 57
2016
Q3
$12K Buy
43,992
+140
+0.3% +$35 ﹤0.01% 57
2016
Q2
$11K Hold
43,852
﹤0.01% 56
2016
Q1
$5K Sell
43,852
-56,791
-56% -$6.16K ﹤0.01% 43
2015
Q4
$11K Sell
100,643
-845
-0.8% -$119 ﹤0.01% 47
2015
Q3
$19K Sell
101,488
-800
-0.8% -$272 ﹤0.01% 45
2015
Q2
$72K Hold
102,288
0.02% 44
2015
Q1
$69K Sell
102,288
-10
-0% -$7 0.01% 52
2014
Q4
$81K Sell
102,298
-600
-0.6% -$410 0.02% 60
2014
Q3
$48K Hold
102,898
0.01% 60
2014
Q2
$51K Sell
102,898
-2,400
-2% -$1.16K 0.01% 48
2014
Q1
$33K Sell
105,298
-50
-0% -$19 0.01% 44
2013
Q4
$36K Sell
105,348
-625
-0.6% -$755 0.01% 49
2013
Q3
$214K Hold
105,973
0.05% 46
2013
Q2
$201K Buy
+105,973
New +$186K 0.05% 46

Zuckerman Investment Group's GCVRZ Position: Q1 2020 in Review

Zuckerman Investment Group sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 41,483 shares — an estimated $36K sold.

Zuckerman Investment Group first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $214K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Zuckerman Investment Group reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Zuckerman Investment Group sold 41,483 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $36K.
  • Zuckerman Investment Group first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
  • Zuckerman Investment Group's Sanofi Contingent Value Rights position peaked at $214K in Q3 2013.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Zuckerman Investment Group's 13F filing for Q1 2020, filed 15 May 2020.